Other Articles and Mentions

Non-Academic Published Articles

• "The Consequences of Rising Healthcare Costs and the Role of Private Equity" (with Cyrus Aghamolla and Jash Jain). The FinReg Blog, Duke Financial Economics Center, August 29, 2023

• "Trust, Transparency, and Complexity" (with Robert C. Merton). Harvard Law School Forum on Corporate Governance and Financial Regulation, February 13, 2023

• "A Financial Innovation to Improve Medical Innovation". See Far Executive Summaries, Spring 2022. The Wells Fargo Advisors Center for Finance and Accounting Research, Washington University in St. Louis, Olin School of Business.

• "How Pay-for-delay Affects Competition and Innovation in the Pharmaceutical Industry" (with Xuelin Li and Andrew W. Lo). VoxEU: CEPR's Policy Portal, August 11, 2021

• "Are Companies More Likely to Go Public If Their Competitors Do?" (with Cyrus Aghamolla). The CLS Blue Sky Blog: Columbia Law School's Blog on Corporations and the Capital Markets, June 11, 2021

• "No-Fault Default, Chapter 11 Bankruptcy, and Financial Institutions" (with Robert C. Merton). Harvard Law School Forum on Corporate Governance and Financial Regulation, February 4, 2021

•  "Does Mandatory Disclosure for Private Firms Increase Their Chances of Going Public?" (with Cyrus Aghamolla). The CLS Blue Sky Blog: Columbia Law School's Blog on Corporations and the Capital Markets, September 17, 2019

• "The Implications of Trust on the Lending Activities of Banks and Fintech Firms" (with Robert C. Merton). VoxEU: CEPR’s Policy Portal, August 21, 2018

• “Clarifying the Roles of Customers and Investors in Financial Institutions” (with Robert C. Merton). See Far Executive Summaries, Spring 2018. The Wells Fargo Advisors Center for Finance and Accounting Research, Washington University in St. Louis, Olin School of Business.

• "A Theory of Efficient Short-Termism". Harvard Law School Forum on Corporate Governance and Financial Regulation, September 17, 2016

• "A Framework for Understanding Financial Institutions" (with Robert C. Merton). Harvard Law School Forum on Corporate Governance and Financial Regulation, August 11, 2015

• "Customers and investors: A framework for financial institutions"  (with Robert C. Merton). VoxEU: CEPR’s Policy Portal, August 1, 2015

• "Competition and R&D: Evidence from biopharma" (with Andrew W. Lo). VoxEU: CEPR’s Policy Portal, March 24, 2015

Media and Other Mentions

• The Wall Street Journal: https://www.wsj.com/articles/new-biden-law-wont-kill-drug-cures-it-will-reshape-them-11673001018

• The Minnesota Daily: https://mndaily.com/274826/news/umn-deed-partner-to-invest-34-5m-in-startup-businesses/ 

• The Christian Science Monitor/Yahoo! News: https://www.csmonitor.com/Business/2022/1129/Why-FTX-collapse-doesn-t-mean-an-end-for-cryptocurrency, https://news.yahoo.com/why-ftx-collapse-doesn-t-141800721.html

• Review of Corporate Finance Studies Paper Spotlight, December 10, 2021: http://sfsrcfs.org/news/paper-spotlight-sharing-rd-risk-in-healthcare-via-fda-hedges/

• NBER Featured Working Papers, November 12, 2021.

• University of Minnesota News Release: https://twin-cities.umn.edu/news-events/grant-innovation-healthcare-funding 

• NBER Featured Working Papers, August 12, 2021.

• The Wichita Eagle:  https://www.kansas.com/news/business/article252257968.html

• Discovery at Carlson, Summer 2021: https://carlsonschool.umn.edu/news/during-financial-crises-cash-payments-can-and-do-help 

• Bloomberg:  https://www.bloomberg.com/news/articles/2021-05-18/stress-tests-for-hospital-lenders-mean-more-pain-for-patients

• See Far Executive Summaries, Spring 2021. The Wells Fargo Advisors Center for Finance and Accounting Research, Washington University in St. Louis, Olin School of Business.

• Review of Corporate Finance Studies Paper Spotlight, November 30, 2020:  http://sfsrcfs.org/news/paper-spotlight-short-termism-managerial-talent-and-firm-value/ 

• Retirement Income Journal, July 11, 2019, “Research Roundup”:  https://retirementincomejournal.com/article/research-roundup-2/

• MILI Exchange, Summer 2019, Issue 19: “What’s in a Name? Biotech vs. Pharma Investments

• The Wall Street Journal:  https://www.wsj.com/articles/trust-and-fintech-1534848211

• Bloomberg:  https://www.bloomberg.com/opinion/articles/2016-09-22/whistle-blowers-and-good-activists 

• Bloomberg:  http://www.bloomberg.com/view/articles/2016-07-19/earnings-bailouts-and-lawsuits

• Bloomberg:  https://www.bloomberg.com/view/articles/2016-09-19/tough-targets-and-short-term-projects

• Regulatory Affairs Professionals Society (RAPS):  http://www.raps.org/Regulatory-Focus/News/2017/04/19/27370/FDA-Hedges-A-Proposal-to-Better-Share-RD-Risks/